We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$308M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$188M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$172M
4
PSA icon
Public Storage
PSA
+$47.9M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$46.9M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$53.7M
2
MCD icon
McDonald's
MCD
+$46.3M
3
SO icon
Southern Company
SO
+$33.8M
4
HEWJ icon
iShares Currency Hedged MSCI Japan ETF
HEWJ
+$26.3M
5
ETP
Energy Transfer Partners L.p.
ETP
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTS
2851
DELISTED
Preferred Apartment Communities, Inc.
APTS
$243K ﹤0.01%
+15,440
New +$233K
GLP icon
2852
Global Partners
GLP
$1.65B
$242K ﹤0.01%
13,405
+1,838
+16% +$34.5K
HAIN icon
2853
Hain Celestial
HAIN
$53.5M
$242K ﹤0.01%
6,233
-69,397
-92% -$2.51M
DOOR
2854
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$242K ﹤0.01%
+3,206
New +$246K
ESPR
2855
DELISTED
Esperion Therapeutics
ESPR
$241K ﹤0.01%
+5,200
New +$191K
S
2856
DELISTED
Sprint Corporation
S
$241K ﹤0.01%
29,387
+12,881
+78% +$107K
XLYS
2857
DELISTED
POWERSHARES S&P SMALLCAP CONSUMER DISCRETIONARY PORT
XLYS
$241K ﹤0.01%
4,405
+16
+0.4% +$875
CLW icon
2858
Clearwater Paper
CLW
$369M
$240K ﹤0.01%
+5,130
New +$248K
TLTD icon
2859
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$681M
$240K ﹤0.01%
3,805
+55
+1% +$3.42K
TRST
2860
Trustco Bank Corp NY
TRST
$958M
$239K ﹤0.01%
6,171
– –
MZF
2861
DELISTED
Managed Duration Inv Grd Muni Fd
MZF
$239K ﹤0.01%
17,308
– –
CIT
2862
DELISTED
CIT Group Inc.
CIT
$239K ﹤0.01%
4,907
-409
-8% -$18.8K
CARO
2863
DELISTED
Carolina Financial Corp.
CARO
$238K ﹤0.01%
+7,357
New +$226K
CEO
2864
DELISTED
CNOOC Limited
CEO
$238K ﹤0.01%
2,177
-599
-22% -$68.8K
ABT icon
2865
CALL
Abbott
ABT
$187B
$236K ﹤0.01%
58,900
-4,500
-7% -$204K
MCI
2866
Barings Corporate Investors
MCI
$343M
$236K ﹤0.01%
15,618
– –
SLRC icon
2867
SLR Investment Corp
SLRC
$705M
$236K ﹤0.01%
+10,794
New +$238K
ANIP icon
2868
ANI Pharmaceuticals
ANIP
$1.88B
$235K ﹤0.01%
5,014
-354
-7% -$17.1K
MDT icon
2869
CALL
Medtronic
MDT
$110B
$235K ﹤0.01%
35,100
-40,100
-53% -$3.38M
IXUS icon
2870
iShares Core MSCI Total International Stock ETF
IXUS
$59.5B
$234K ﹤0.01%
4,085
+426
+12% +$24.2K
PIO icon
2871
Invesco Global Water ETF
PIO
$283M
$234K ﹤0.01%
+9,841
New +$231K
EVG
2872
Eaton Vance Short Duration Diversified Income Fund
EVG
$142M
$233K ﹤0.01%
16,570
+167
+1% +$2.35K
TCOM icon
2873
CALL
Trip.com Group
TCOM
$29.1B
$233K ﹤0.01%
+38,800
New +$2.06M
BSCP
2874
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$232K ﹤0.01%
+11,259
New +$232K
FIVN icon
2875
FIVE9
FIVN
$2.17B
$232K ﹤0.01%
10,790
+65
+0.6% +$1.33K
113 114
115
116 117

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.